Home » Baxter Wins FDA Clearance of Clindamycin Injection
Baxter Wins FDA Clearance of Clindamycin Injection
The FDA has cleared Baxter’s ready-to-use clindamycin injection in saline in three prescribed formulations (300mg/50mL, 600mg/50mL, 900mg/50mL).
Clindamycin injection in saline provides an alternative to administer to patients for whom the use of dextrose is contraindicated or undesirable.
Baxter’s ready-to-use clindamycin injection in saline is now available in the U.S.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May